Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT05378360
Eligibility Criteria:
Inclusion Criteria:
1. Age: older than 19
2. Eastern Cooperative Oncology Group (ECOG) performance status 0 -2
3. Patients who have Rash acneiform Gr≥2 (NCI CTCAE v5.0)
4. Patients who are currently administering EGFR TKI or EGFR mAb
Exclusion Criteria:
1. Known allergies, hypersensitivity, or intolerance to study drugs, chemotherapy drugs using this clinical trial
2. Patients with a history of topical medication
* Steroids within 3 days prior to baseline visit
* Antihistamine, Antipruritic agents, Antibiotics agents within 1 week prior to baseline visit
* Tacrolimus, Pimecrolimus within 2 weeks prior to baseline visit
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT05378360
Study Brief:
Protocol Section:
NCT05378360